Navigating What’s Next in Interventional Psychiatry-View Recording

Video Transcription

Video Summary

This video is a summary of a conference on interventional psychiatry, featuring insights from experts like Dr. Owen Muir, Dr. Eugene Lipov, and Dr. Nolan Williams. They discuss advances and challenges in treatments like stellate ganglion block for PTSD and transcranial magnetic stimulation (TMS) for depression.<br /><br />Dr. Eugene Lipov explains the stellate ganglion block, a procedure targeting the sympathetic nervous system to rapidly alleviate PTSD symptoms, emphasizing the importance of recognizing PTSD as a biological change. He highlights the procedure's safety and efficacy, supporting these claims with past successful studies and ongoing research at NYU.<br /><br />Dr. Nolan Williams introduces a novel biomarker for depression treatment and discusses the efficiency of Theta Burst Stimulation, a type of TMS. He explains that this approach reorganizes TMS application in space, time, and dose to achieve better outcomes more quickly. Williams emphasizes the need for the precise targeting of brain networks to maximize the effectiveness of treatments.<br /><br />Dr. Owen Muir focuses on the complexities of getting novel interventions reimbursed. He explains the different incentives of government, fully funded, and self-funded insurance plans, stressing the importance of aligning treatment efficacy with these varying economic interests. Muir advocates for more real-world evidence and post-marketing data to convince insurers of new treatments' efficacy, aiming to improve patient access.<br /><br />The conference highlights the importance of innovation, collaboration, and strategic advocacy in advancing interventional psychiatry to improve treatment outcomes and accessibility for patients.

Keywords

interventional psychiatry

stellate ganglion block

PTSD treatment

transcranial magnetic stimulation

TMS

depression biomarker

Theta Burst Stimulation

Dr. Owen Muir

Dr. Eugene Lipov

Dr. Nolan Williams

insurance reimbursement

treatment efficacy

patient access